UK Products

This page is intended for members of the public.

Medical Information

If you have a medical information question or product quality concern regarding a Daiichi Sankyo product you can contact our Medical Information service on 0800 028 5122 or by email to medinfo@daiichi-sankyo.co.uk.

Please note: Pharmaceutical company Medical Information services cannot provide personal medical advice.

Side Effect Reporting

Side effects (adverse events) should be reported. The documents for some medicines also display an inverted black triangle symbol indicating that they are subject to additional monitoring to support the quick identification of new safety information.

If you are a patient and experience any side effects while taking a Daiichi Sankyo product, please talk to your doctor, pharmacist or nurse. You can also report side effects directly to the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.  By reporting side effects, you can help build the knowledge regarding the safety of the medicine.

If you are a health professional, adverse event reporting forms and information can be found at www.mhra.gov.uk/yellowcard (or search for MHRA Yellow Card in Google Play or Apple App store). Adverse events should also be reported to Daiichi Sankyo on 0800 028 5122 or by email to pharmacovigilance@daiichi-sankyo.co.uk

Products

Product Summary of Product
Characteristics (SmPC)
Patient Information
Leaflet (PIL)
Enhertu▼
(trastuzumab deruxtecan)

Great Britain SmPC

Northern Ireland SmPC

Great Britain PIL

Northern Ireland PIL

Lixiana
(edoxaban tosilate)

Great Britain SmPC

Northern Ireland SmPC

Great Britain PIL

Northern Ireland PIL

Nilemdo▼
(bempedoic acid)

Great Britain SmPC

Northern Ireland SmPC

Great Britain PIL

Northern Ireland PIL

Nustendi▼
(bempedoic acid, ezetimibe)

Great Britain SmPC

Northern Ireland SmPC

Great Britain PIL

Northern Ireland PIL

Olmetec
(olmesartan medoximil)
UK SmPC UK PIL
Olmetec Plus 20 mg/12.5 mg
& 20 mg/12.5 mg
(olmesartan medoximil, hydrochlorothiazide)
UK SmPC UK PIL
Olmetec Plus 40 mg/12.5 mg
olmesartan medoximil, hydrochlorothiazide)
UK SmPC UK PIL
Sevikar
(olmesartan medoximil, amplodipine besilate)
UK SmPC UK PIL
Sevikar HCT
(olmesartan medoximil, amplodipine besilate, hydrochlorothiazide)
UK SmPC UK PIL

 

 

DSC/23/0089 April 2023

back to top